Closed Circuit Breathing Device Could Transform The Lives Of Patients With Chronic Obstructive Pulmonary Disease
A UNIQUE partnership between Smiths Medical, part of the FTSE 100 technology business Smiths Group, and University College London (UCL) has resulted in the development of a breakthrough clinical device that could transform the lives of patients with COPD across the world. COPD will be the third leading cause of death worldwide by 2030, according to the World Health Organisation (WHO).
(more...)
(more...)
